🇺🇸 FDA
Patent

US 11692030

Biomarkers and methods for detection of seizures and epilepsy

granted A61PA61P25/08

Quick answer

US patent 11692030 (Biomarkers and methods for detection of seizures and epilepsy) held by Cognizance Biomarkers, LLC expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cognizance Biomarkers, LLC
Grant date
Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P25/08